Zhejiang Tianyu Pharmaceutical's share price drop may be due...

Zhejiang Tianyu Pharmaceutical's share price drop may be due to the broader market's 15% decline and the company's EPS loss. Despite the sell-off, long-term investors might see this as an opportunity given the 4% annual return over five years.